Get started
Work

Supplementary Figure S2 from Promoter Methylation of CDO1 Identifies Clear-Cell Renal Cell Cancer Patients with Poor Survival Outcome

Year: 2023
Type: supplementary-materials
Abstract: Five-year survival of clear-cell renal cell cancer patients from the TCGA according to CDO1 methylation in patients A) aged <55 years, B) aged {greater than or equal to}55 to <65 years, C) aged {greater than or equal to} 65 to <75 years and D) aged {greater than or equal to}75 years at diagnosis.
DOI: 10.1158/1078-0432.22455857
Authors: Ivette A.G. Deckers, Leo J. Schouten, Leander Van Neste, Iris J.H. van Vlodrop, Patricia M.M.B. Soetekouw, Marcella M.L.L. Baldewijns, Jana Jeschke, Nita Ahuja, James G. Herman, Piet A. van den Brandt, Manon van Engeland
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361884031
Cites:
Cited by:
Related to: 10